Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US First non-mRNA combination vaccine candidates that include two already licensed ...

The European Medicines Agency (EMA) has validated Chiesi Global Rare Diseases and Protalix BioTherapeutics’ submission to ...

Paris: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine ...

In the current global market landscape, major stock indexes have shown mixed results with growth stocks leading the charge, as evidenced by the significant outperformance of growth shares over value ...

Veterinary Vaccines Market Report Introduction 2 Veterinary Vaccines Market Executive Summary 3 Competitive Landscape ...

Background and aims Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic ...

Huonslab, a subsidiary of Huons Global (KOSDAQ: 084110), announced today the successful enrollment and administration of the first patient in its pivotal Phase 1 clinical study of Hydizymetm ...

Matrix-M™ adjuvant, today announced that the first participants have been dosed in its COVID-19-Influenza Combination (CIC) and stand-alone seasonal influenza Phase 3 trial. The trial will evaluate ...

Vernon Bernardino, an analyst from H.C. Wainwright, maintained the Buy rating on Novavax (NVAX – Research Report). The associated price target ...

Reducing the burden of all-cause mortality after influenza hospitalization will require earlier treatment initiation and ...

Pyrrolizidine alkaloids (PAs), widely distributed in plants, are known to induce liver failure. Hepatic platelet accumulation has been reported during ...